Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin branded versus generic comparative bioavailability crossover study
NL-OMON35125Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of gabapentin in epilepsy, sponsored by Maastricht University Medical Center+. Primary endpoints: Pharmacokinetic bioavailability comparison, 90% confidence intervals for AUC0-t ratio and 2 more. Started Sep 2011; status: active, not recruiting.
02
Drugs
gabapentin
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON35125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35125.